Pilocarpine and artificial saliva for the treatment of xerostomia and xerophthalmia of Sjogren's syndrome: A double blind control trial
British Journal of Dermatology Feb 22, 2018
Cifuentes M, et al. - The effectiveness of pilocarpine and artificial saliva was evaluated and compared as symptomatic treatments for xerostomia and xerophthalmia in cases with Sjogren's Syndrome (SS). For enhancing salivary and lachrymal secretion in patients with SS, pilocarpine was noted to be more efficacious than artificial saliva. It was the first trial that compared the effectiveness of pilocarpine and artificial saliva as treatments for xerostomia and xerophthalmia in SS.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries